Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Concurrent versus sequential radiotherapy for small cell lung cancer.

H Tsukada1, A Yokoyama, K Goto

  • 1Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata, Japan.

Seminars in Oncology
|August 2, 2001
PubMed
Summary

Early thoracic radiotherapy combined with chemotherapy offers superior survival for limited-stage small cell lung cancer. This integrated approach, particularly with cisplatin/etoposide, is now considered standard treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized phase II study of cisplatin, irinotecan and etoposide combinations administered weekly or every 4 weeks for extensive small-cell lung cancer (JCOG9902-DI).

Annals of oncology : official journal of the European Society for Medical Oncology·2003
Same author

T-helper 1 cells induce alveolitis but do not lead to pulmonary fibrosis in mice.

The European respiratory journal·2003
Same author

[Alcohol and oropharyngolaryngeal and digestive tract cancer].

Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence·2002
Same author

A study of the combination of gemcitabine hydrochloride (LY188011) and cisplatin in non-small-cell lung cancer: 3-week schedule.

International journal of clinical oncology·2002
Same author

A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients.

Cancer chemotherapy and pharmacology·2002
Same author

Three novel mutations of the RPGR gene exon ORF15 in three Japanese families with X-linked retinitis pigmentosa.

American journal of medical genetics·2001

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Oncology

Background:

  • Limited-stage small cell lung cancer (SCLC) treatment benefits from combined-modality therapy.
  • Chemotherapy resistance is a concern, prompting investigation into optimal treatment sequencing.

Purpose of the Study:

  • To evaluate the impact of early versus delayed thoracic radiotherapy timing in limited-stage SCLC.
  • To determine if early chemoradiation improves long-term survival rates.

Main Methods:

  • Review of meta-analyses and controlled trials comparing thoracic radiotherapy timing.
  • Analysis of three recent trials using cisplatin/etoposide with early or delayed radiotherapy.

Main Results:

  • Two meta-analyses confirm thoracic radiotherapy plus chemotherapy superiority over chemotherapy alone.

Related Experiment Videos

  • Three recent trials demonstrate early radiotherapy is superior to delayed radiotherapy.
  • Early integrated chemoradiation with cisplatin/etoposide achieved >20% long-term survival.

    • Conclusions:

    • Early concurrent thoracic radiotherapy with cisplatin/etoposide-based chemotherapy is superior for limited-stage SCLC.
    • This integrated approach should be the standard of care for improved patient outcomes.